Loading clinical trials...

A Retrospective Cohort Study of Infusion Reactions Due to Vectibix | Clinical Trials | Clareo Health

COMPLETEDNCT01156090

A Retrospective Cohort Study of Infusion Reactions Due to Vectibix

The purpose of this study is to identify approximately 100 - 150 patients who have received Vectibix (Panitumumab) in offices and clinics located in Tennessee, North Carolina, South Carolina, and Nort...

Lead sponsor: SCRI Development Innovations, LLC•7 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

Not Yet RecruitingPhase 4

A Clinical Trial on the Outcomes of Comprehensive Enhanced Prophylaxis Management (CEPM) in Chinese Patients With EGFR-Mutated Advanced NSCLC Receiving Amivantamab-Based Regimens

NCT07469488 · NSCLC (Advanced Non-small Cell Lung Cancer), VTE (Venous Thromboembolism), and more

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: August 28, 2015Terms

Trial snapshot

StatusCOMPLETED

Phase—

Enrollment141

Start dateJun 2010

Last updatedAug 28, 2015

Condition

Infusion Reaction

Locations shown

Northeast Arkansas Clinic

Jonesboro, Arkansas

Medical Oncology Associates of Augusta

Augusta, Georgia

Northeast Georgia Medical Center

Gainesville, Georgia

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: August 28, 2015Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions